Grant programme · France
EP PerMed
EP PerMed (France): 95 grants in the last 24 months to 93 recipients. It funds most often: Research and development projects. Data as of 17 November 2026; updated daily.
- Grants in the last 24 months
- 95
- Recipients
- 93
- Total, last 24 months
- ≈ €5,200,000
- Open calls
- 0
- Calls on the site
- 0
Open calls
No records yet.
Latest grants
| Project | Recipient | Grant | Date |
|---|---|---|---|
| BlaCaPOx: Pharmaco-omics strategies to guide personalised medicine in BCG- treated patients with Bladder Cancer | Université des Patients | €176,998 | 1 May 2026 |
| BlaCaPOx: Pharmaco-omics strategies to guide personalised medicine in BCG- treated patients with Bladder Cancer | GRUPO ESPAÑOL DE PACIENTES CON CÁNCER | — | 1 May 2026 |
| Molecular-based stratification of metastatic papillary renal cell carcinoma to personalize treatment strategies | Technische Universität Dresden (TUD) | — | 1 May 2026 |
| BlaCaPOx: Pharmaco-omics strategies to guide personalised medicine in BCG- treated patients with Bladder Cancer | FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P- Andalusian Public Foundation Progress and Health (FPS ). | — | 1 May 2026 |
| BlaCaPOx: Pharmaco-omics strategies to guide personalised medicine in BCG- treated patients with Bladder Cancer | Ludwig-Maximilians-Universität, Klinikum der Universität München | — | 1 May 2026 |
| BIOMERGE. Causal biomarkers to predict acute treatment response in stroke through multi merge omic data. | Institut du Cerveau | €269,999 | 1 May 2026 |
| Molecular-based stratification of metastatic papillary renal cell carcinoma to personalize treatment strategies | Ruperto-Carola Universität Heidelberg | — | 1 May 2026 |
| Molecular-based stratification of metastatic papillary renal cell carcinoma to personalize treatment strategies | Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre | — | 1 May 2026 |
| BIOMERGE. Causal biomarkers to predict acute treatment response in stroke through multi merge omic data. | Syreon Kutató Intézet Kft. | — | 1 May 2026 |
| Molecular-based stratification of metastatic papillary renal cell carcinoma to personalize treatment strategies | Fondazione IRCCS Istituto Nazionale dei Tumori di Milano | — | 1 May 2026 |
Most grants went to
- Direction de la Recherche et de l'Innovation de l' AP-HP 2
- Idryma Iatroviologikon ereunon akademias athinon 2
- Centre de Recherche des Cordeliers 1
- Center for Research in Transplantation and Translational Immunology 1
- Institut des Maladies Métaboliques et Cardiovasculaires 1
- Centre International de Recherche en Infectiologie 1
- Centre de Recherche en Immunologie des Maladies Virales, Auto-Immunes, Hematologiques et Bacteriennes 1
- Institut de Génétique et de Biologie Moléculaire et Cellulaire 1
- Centre de recherche en cancérologie de Marseille 1
- OSE Immunotherapeutics 1
What the money buys
By country
Grant calendars
Grants for projects that started between 17 November 2024 and 17 November 2026; amounts in euro at the Eurostat rate of each year.
Questions and answers
- When does EP PerMed open calls?
- No call is open right now.
- Who gets grants from EP PerMed?
- Most grants in the last 24 months: Direction de la Recherche et de l'Innovation de l' AP-HP (2), Idryma Iatroviologikon ereunon akademias athinon (2) and CENTRE DE RECHERCHE DES CORDELIERS (1).
- What does EP PerMed fund?
- Most often: Research and development projects.